AGU
MCID: ASP002
MIFTS: 53

Aspartylglucosaminuria (AGU) malady

Neuronal diseases, Bone diseases, Metabolic diseases, Fetal diseases categories

Summaries for Aspartylglucosaminuria

About this section
Sources:
21Genetics Home Reference, 42NIH Rare Diseases, 63Wikipedia, 46OMIM, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
NIH Rare Diseases:42 Aspartylglycosaminuria is a very rare lysosomal storage disease that causes a progressive decline in mental functioning. infants with aspartylglycosaminuria appear healthy at birth with signs and symptoms beginning around the age of 2 or 3. major symptoms may include coarse facial features, spine and eye deformities, behavior problems, and intellectual disability.  symptoms result from a deficiency in an enzyme called aspartylglycosaminidase, which leads to an accumulation of a protein called glycoasparagine in the body tissues and  increased excretion of this protein in the urine. aspartylglycosaminuria is inherited in an autosomal recessive fashion and caused by mutations in the aga gene. it is commonly seen in individuals of finnish decent. last updated: 8/17/2011

MalaCards: Aspartylglucosaminuria, also known as aspartylglycosaminuria, is related to fucosidosis and neuronal ceroid lipofuscinosis, and has symptoms including metabolic anomalies, anomalies of teeth and dentition and multiple caries. An important gene associated with Aspartylglucosaminuria is AGA (aspartylglucosaminidase), and among its related pathways is Lysosome. Affiliated tissues include bone, liver and skin.

Genetics Home Reference:21 Aspartylglucosaminuria is a condition that causes a progressive decline in mental functioning.

Wikipedia:63 Aspartylglucosaminuria ( commonly referred to as AGU) is an inherited disease that is characterized by a... more...

Description from OMIM:46 208400

Aliases & Classifications for Aspartylglucosaminuria

About this section
Sources:
8Disease Ontology, 9diseasecard, 42NIH Rare Diseases, 21Genetics Home Reference, 46OMIM, 10DISEASES, 48Orphanet, 60UMLS, 20GeneTests, 22GTR, 34MeSH, 35MESH via Orphanet, 26ICD10 via Orphanet, 57SNOMED-CT via Orphanet, 61UMLS via Orphanet
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Metabolic diseases, Fetal diseases
Anatomical: Neuronal diseases, Bone diseases


Characteristics (Orphanet epidemiological data):

48
aspartylglucosaminuria:
Inheritance: Autosomal recessive; Age of onset: Childhood


Aliases & Descriptions:

aspartylglucosaminuria 8 9 42 21 46 10 48 60
aspartylglycosaminuria 8 42 20 22 21
aspartylglucosaminidase deficiency 8 21 48
glycosylasparaginase deficiency 8 42 21
aspartylglucosamidase deficiency 42 60
aga deficiency 42 21
aspartylglucosamidase deficiency 21
aspartylglucosaminidase 9
agu 42


External Ids:

Disease Ontology8 DOID:0050461
OMIM46 208400
MeSH34 D054880
MESH via Orphanet35 C538402, D054880
ICD10 via Orphanet26 E77.1
SNOMED-CT via Orphanet57 54954004
UMLS via Orphanet61 C0268225, C2931840

Related Diseases for Aspartylglucosaminuria

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Graphical network of diseases related to Aspartylglucosaminuria:



Diseases related to aspartylglucosaminuria

Clinical Features for Aspartylglucosaminuria

About this section
Sources:
46OMIM, 48Orphanet
See all sources

Clinical features from OMIM:

208400

Clinical synopsis from OMIM:

208400

Symptoms:

48 (show all 41)
  • metabolic anomalies
  • anomalies of teeth and dentition
  • multiple caries
  • pectus carinatum
  • abnormal vertebral size/shape
  • ulnar/cubital anomaly/absence/agenesis/hypoplasia/abnormal ulnar/cubital ray
  • macroorchidism/macrotestes
  • cortical anomaly/thick bone cortical layer
  • flat foot
  • vascular anomalies of skin/mucosae
  • malabsorption/chronic diarrhea/steatorrhea
  • anomalies of bones/skeletal anomalies
  • restricted joint mobility/joint stiffness/ankylosis
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • hyperkinesia/dyskinesia
  • umbilical hernia
  • microtia/cryptomicrotia/anotia/external auditory canal/pinnae aplasia/hypoplasia
  • storage liver disease
  • macroglossia/tongue protrusion/proeminent/hypertrophic
  • coarse face
  • dense/thickened skull/calvarium/cranial/facial hyperostosis
  • speech troubles/aphasia/dysphasia/echolalia/mutism/logorrhea/dysprosodia
  • sleep and vigilance disorders
  • seizures/epilepsy/absences/spasms/status epilepticus
  • scoliosis
  • large face
  • autosomal recessive inheritance
  • hepatomegaly/liver enlargement (excluding storage disease)
  • splenomegaly
  • thickened/hypertrophic/fibromatous gingivae
  • thick lips
  • short/small nose
  • broad nose/nasal bridge
  • facial dysmorphism
  • arthritis/synovitis/synovial proliferation
  • repeat respiratory infections
  • prognathism/prognathia
  • psychic/behavioural troubles
  • inguinal/inguinoscrotal/crural hernia
  • chronic/relapsing otitis
  • hypertelorism

Drugs & Therapeutics for Aspartylglucosaminuria

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Aspartylglucosaminuria

Drug clinical trials:

Search ClinicalTrials for Aspartylglucosaminuria

Search NIH Clinical Center for Aspartylglucosaminuria

Search CenterWatch for Aspartylglucosaminuria

Genetic Tests for Aspartylglucosaminuria

About this section
Sources:
20GeneTests, 22GTR
See all sources

Genetic tests related to Aspartylglucosaminuria:

id Genetic test Affiliating Genes
1 Aspartylglycosaminuria20 22 AGA

Anatomical Context for Aspartylglucosaminuria

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Aspartylglucosaminuria:

32
Bone, Liver, Skin, Spleen, Thyroid, Eye, Bone marrow, Brain, Tongue, Testes, Kidney

Animal Models for Aspartylglucosaminuria or affiliated genes

About this section

Publications for Aspartylglucosaminuria

About this section
Sources:
50PubMed
See all sources

Articles related to Aspartylglucosaminuria:

(show top 50)    (show all 83)
idTitleAuthorsYear
1
Aspartylglucosaminuria: unusual neonatal presentation in qatari twins with a novel aspartylglucosaminidase gene mutation and 3 new cases in a Turkish family. (23271757)
2014
2
Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria. (18568562)
2008
3
Sleep disturbances in aspartylglucosaminuria (AGU): a questionnaire study. (16944277)
2006
4
Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse. (16518877)
2006
5
A novel aspartylglucosaminuria mutation affects translocation of aspartylglucosaminidase. (15365992)
2004
6
Bone marrow transplantation in young aspartylglucosaminuria mice: improved clearance of lysosomal storage in brain by using wild type as compared to heterozygote donors. (15489878)
2004
7
Bone marrow transplantation for aspartylglucosaminuria: follow-up study of transplanted and non-transplanted patients. (11174635)
2001
8
Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria. (10353787)
1999
9
Origin of Finnish mutations causing aspartylglucosaminuria. (10783529)
1999
10
Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. (10226749)
1999
11
Correction of peripheral lysosomal accumulation in mice with aspartylglucosaminuria by bone marrow transplantation. (10480438)
1999
12
Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients. (9425233)
1998
13
Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouse. (9930336)
1998
14
Chronic arthritis in patients with aspartylglucosaminuria. (9632076)
1998
15
Characteristic dental arches and occlusion in patients with aspartylglucosaminuria. (9338856)
1997
16
Aspartylglucosaminuria among Palestinian Arabs. (9427148)
1997
17
Aspartylglucosaminuria: radiologic course of the disease with histopathologic correlation. (9309520)
1997
18
DNA-based carrier screening in primary healthcare: screening for aspartylglucosaminuria mutations in maternity health offices. (8787695)
1996
19
Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene. (7627186)
1995
20
Finnish-type aspartylglucosaminuria detected by oligonucleotide ligation assay. (7813081)
1995
21
Aspartylglucosaminuria in northern Norway: a molecular and genealogical study. (8064811)
1994
22
Fibroblast expression of collagens and proteoglycans is altered in aspartylglucosaminuria, a lysosomal storage disease. (8312372)
1994
23
Follow-up in patients with aspartylglucosaminuria. Part I. The course of intellectual functions. (8518524)
1993
24
Applications of a new fluorimetric enzyme assay for the diagnosis of aspartylglucosaminuria. (8127068)
1993
25
Follow-up in patients with aspartylglucosaminuria. Part II. Adaptive skills. (8338997)
1993
26
Early clinical symptoms and incidence of aspartylglucosaminuria in Finland. (8338996)
1993
27
Aspartylglucosaminuria (AGU): protein and gene structure of normal and mutated aspartylglucosaminidase. (8373629)
1993
28
Expression of aspartylglucosaminidase in human tissues from normal individuals and aspartylglucosaminuria patients. (7685790)
1993
29
Dissection of the molecular pathology of aspartylglucosaminuria provides the basis for DNA diagnostics and future therapeutic interventions. (8322015)
1993
30
Molecular analysis of the aspartylglucosaminidase gene in Japanese patients with aspartylglucosaminuria]. (8411707)
1993
31
Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease. (1301945)
1992
32
Human aspartylglucosaminidase. A biochemical and immunocytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts. (1530592)
1992
33
Spectrum of mutations in aspartylglucosaminuria. (1722323)
1991
34
Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. (1703489)
1991
35
Deletion of exon 8 causes glycosylasparaginase deficiency in an African American aspartylglucosaminuria (AGU) patient. (1879549)
1991
36
In vitro mutagenesis helps to unravel the biological consequences of aspartylglucosaminuria mutation. (1765378)
1991
37
Linkage of aspartylglucosaminuria (AGU) to marker loci on the long arm of chromosome 4. (1973404)
1990
38
First-trimester prenatal diagnosis of aspartylglucosaminuria. (2798347)
1989
39
Aspartylglucosaminuria in a Puerto Rican family: additional features of a panethnic disorder. (3228136)
1988
40
Prenatal diagnosis and fetal pathology of aspartylglucosaminuria. (6507482)
1984
41
Extra heating of TLC plates detects two lysosomal storage diseases, aspartylglucosaminuria and fucosidosis, during routine urinary amino acid screening. (6627685)
1983
42
Aspartylglucosaminuria in the United States. (6883788)
1983
43
Automated ion-exchange chromatography in the detection of aspartylglucosaminuria. (7391183)
1980
44
Isolation of the liver N-aspartyl-beta-glucosaminidase in aspartylglucosaminuria. (942387)
1976
45
Letter: Leukocyte function in aspartylglucosaminuria. (1185361)
1975
46
Picture of the Month. Aspartylglucosaminuria. (4821322)
1974
47
Detection of heterozygotes for aspartylglucosaminuria (AGU) in cultured fibroblasts. (4464238)
1974
48
Aspartylglucosaminuria. II. Biochemical studies on brain, liver, kidney and spleen. (5044002)
1972
49
Biochemical and fine structural studies in aspartylglucosaminuria. (4663894)
1972
50
Eleven new cases of aspartylglucosaminuria. (5512217)
1970

Genetic Variations for Aspartylglucosaminuria

About this section
Sources:
62UniProtKB/Swiss-Prot
See all sources

Genetic disease variations for Aspartylglucosaminuria:

62 (show all 12)
id Symbol AA change Variation ID SNP ID
1AGAp.Gly60AspVAR_005069
2AGAp.Ser72ProVAR_005070
3AGAp.Ala101ValVAR_005071
4AGAp.Arg161GlnVAR_005072rs192195150
5AGAp.Cys163SerVAR_005073rs121964904
6AGAp.Gly302ArgVAR_005074
7AGAp.Cys306ArgVAR_005075
8AGAp.Gly100GluVAR_015428
9AGAp.Phe135SerVAR_015429
10AGAp.Gly252GluVAR_015430
11AGAp.Gly252ArgVAR_015431
12AGAp.Thr257IleVAR_015432

Expression for genes affiliated with Aspartylglucosaminuria

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Aspartylglucosaminuria

Search GEO for disease gene expression data for Aspartylglucosaminuria.

Pathways for genes affiliated with Aspartylglucosaminuria

About this section
Sources:
29KEGG
See all sources

Pathways related to Aspartylglucosaminuria according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.0AGA, MFSD8

Compounds for genes affiliated with Aspartylglucosaminuria

About this section

GO Terms for genes affiliated with Aspartylglucosaminuria

About this section

Products for genes affiliated with Aspartylglucosaminuria

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Aspartylglucosaminuria

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet